July 9, 2012
Clessidra, Avista reach deal to buy 50 pct of Rottapharm
By Massimo Gaia
Private equity firms Clessidra Capital Partners and Avista Capital Partners have reached an agreement to buy 50 percent of family-owned Italian pharmaceutical group Rottapharm-Madaus...
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.